FDA Releases Final Guidance On SNIs for Drug Packaging

摘要

Drugmakers will have more leeway for serial numbers on packaging that would help authenticate prescription drugs in the supply chain, according to the FDA's first final guidance on standardized numerical identifiers (SNIs).rnThe SNI will include the product's national drug code (NDC) plus a recommended serial number of as many as 20 characters, lengthening the serial number from the one suggested in the draft guidance to accommodate high-volume products and allowing letters to be used in the sequence.